The Scuttlebutt
Subscribe
Sign in
Home
Notes
Chat
📰 Editions
🧭 Topics
🎙️ Sources
🗣️ People
📈 Investments
💡 Themes
🗂️ Asset Classes
Archive
About
Pfizer - $PFE
Up to half the world's experimental drugs now start in China, say Bloomberg reporters
8 insights: Why Merck's next cornerstone cancer drug was discovered in China, what the 2015 rule change did to generics, and the worry US pharma is…
3 hrs ago
•
The Scuttlebutt
Bloomberg reporters: 16% of pharma licensing deals involved China in 2022, now half
12 insights: The Merck cancer drug that came out of Sichuan, what the 2015 regulatory overhaul did, and why Washington cannot agree on whether to stop…
Sep 16
•
The Scuttlebutt
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts